Fitxers

606220.pdf (310.09 KB)

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

2008-10-28

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/147097

PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1038/sj.bjc.6604747

Resum

Phosphatase PRL-3 has been involved in different types of cancer, especially in metastases from colorectal carcinoma (CRC). In this study, we explored both isoforms of PRL-3 as a biomarker to predict the recurrence of stage IIIB-C CRC. Overexpression of PRL-3 was investigated in primary human colorectal tumours (n=20) and hepatic metastases (n=36) xenografted in nude mice, samples characterised by absence of human non-tumoral cells, showing a high degree of expression in metastases (P=0.001). In 27 cases of matched normal colonic mucosa/primary tumour/hepatic metastases, PRL-3 overexpression occurs in primary tumours vs normal mucosa (P=0.001) and in hepatic metastases vs primary tumours (P=0.045). Besides, our results in a series of 80 stage IIIB-C CRC primary tumours showed that high levels of PRL-3 were an independent predictor of metastasis (P<0.0001; OR: 9.791) in multivariate analysis of a binary logistic regression and that PRL-3 expression tightly correlates with parameters of bad outcome. Moreover, PRL-3 expression associated with poor outcome in univariate (P<0.0001) and multivariate Cox models (hazard ratio: 3.322, 95%, confidence interval: 1.405-7.852, P=0.006). In conclusion, PRL-3 is a good marker of aggressiveness of locally advanced CRS and a promising predictor of distant metastases. Nevertheless, for prognosis purposes, it is imperative to validate the cutoff value of PRL-3 expression in a larger and consecutive series and adjuvant setting.

Matèries

Metabolisme, Càncer colorectal, Patologia, Càncer de fetge

Matèries (anglès)

Metabolism, Colorectal cancer, Pathology, Liver cancer

Citació

Col·leccions

Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

MOLLEVÍ, David G., et al. PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness. British Journal of Cancer. 2008. Vol. 99, num. 10, pags. 1718-1725. ISSN 0007-0920. [consulted: 28 of June of 2026]. Available at: https://hdl.handle.net/2445/147097

Exportar metadades

JSON - METS

Compartir registre